News

Stop drug secrecy, says government watchdog

BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6958.831 (Published 01 October 1994) Cite this as: BMJ 1994;309:831
  1. A Tonks

    The British government must take the lead in ending the secrecy surrounding the manufacture, licensing, and marketing of new drugs in Europe, says the National Consumer Council in a report published last week. According to the council, patients are denied access to detailed information on safety, quality, and efficacy of new drugs to protect drug companies from revealing trade secrets to their rivals.

    Under a new European drugs regulating system, to be launched next year, drugs approved by the licensing agency in one country will be fast …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe